Fig. 3

Survival curve of endometrial cancer patients using the Kaplan–Meier method and the log-rank test. A Overall survival curves for patients with TET2⁺5hmC⁺(blue line), TET2⁻5hmC⁺ /TET2⁺5hmC⁻ (red line) and TET2⁻5hmC⁻(green line). B-D, Analysis of the association between TET2⁺5hmC⁺(blue line), TET2⁻5hmC⁺ /TET2⁺5hmC⁻ (red line) and TET2⁻5hmC⁻(green line) level and poor overall survival in patients with FIGO Stage I, Stage II, and Stage III